Navigation Links
NADDI and the C.A.R.E.S. Alliance Join Attorney General Bondi in Fight Against Prescription Drug Abuse
Date:8/16/2011

TALLAHASSEE, Fla., Aug. 16, 2011 /PRNewswire-USNewswire/ -- The National Association of Drug Diversion Investigators (NADDI) and the C.A.R.E.S. (Collaborating and Acting Responsibly to Ensure Safety) Alliance(SM) have joined Attorney General Pam Bondi in addressing a serious public health issue in Florida – prescription drug abuse. Attorney General Bondi sponsored a proclamation today that makes August 27 a statewide Drug Take Back Day. NADDI and the C.A.R.E.S. Alliance are co-sponsoring the Take Back Day and invite Floridians to fight prescription drug abuse by safely disposing of unused prescription drugs at specified locations.

NADDI, an organization that focuses on drug diversion activities, has long supported drug take back initiatives. In their efforts to address the growing problem of abuse and misuse, the organization shares investigative information and works with a wide variety of organizations and law enforcement on pharmaceutical drug diversion. NADDI recently joined the C.A.R.E.S. Alliance, a coalition of ten national patient safety, provider and drug diversion organizations focused on reducing opioid pain medication abuse and increasing responsible prescribing habits.

In addition to co-sponsoring the Florida statewide Drug Take Back Day, the C.A.R.E.S. Alliance has ongoing programs and initiatives throughout the country focused on curbing prescription drug diversion, abuse and misuse. The coalition's comprehensive website (www.caresalliance.org) includes information for physicians, pharmacists, patients and their families. Physicians and pharmacists can find tools for prescribing, screening and assessing patients, and patients and their families can find tips for the safe use and handling of their medications.

The C.A.R.E.S. Alliance was created in response to the devastating impact prescription drug abuse and misuse has on communities throughout the country. According to the Centers for Disease Control and Prevention, prescription drug overdoses killed seven Floridians per day in 2009. The C.A.R.E.S. Alliance and NADDI believe that national, state and local cooperation is critical in bending the curve of abuse in Florida and across the country.  

"We all play a role in combating abuse and misuse and improving patient and public safety," said the C.A.R.E.S. Alliance representative Herbert Neuman, M.D., Vice President of Medical Affairs and Chief Medical Officer – Pharmaceuticals for Covidien. "A successful long-term solution can be found, but only through collaboration with groups like NADDI, more focused community education and better resources for prescribers and pharmacists."

Charlie Cichon, Executive Director of NADDI, agrees with the C.A.R.E.S. Alliance's focus on collaboration. "It is unique partnerships like these that really make a difference. We believe that collaboration through this initiative and others will further our progress against illegal diversion of legitimate, prescription medicines."

On August 27, through a unique partnership, more than 70 pharmacies and law enforcement offices throughout Florida will participate in the Drug Take Back Day and will be accepting unused medications. To identify your community partners and to find the drop off site nearest you, please visit www.projectdrugdrop.com or www.caresalliance.org.

About the C.A.R.E.S. Alliance

Launched in September 2010, the C.A.R.E.S. Alliance is a coalition of ten national patient safety, provider and drug diversion organizations focused on reducing opioid pain medication abuse and increasing responsible prescribing habits. The C.A.R.E.S. Alliance was created by Covidien, a pharmaceutical manufacturer, to ensure the safe use of all medications by collaboratively developing and sharing tools and resources for all stakeholders.  

About NADDI

The National Association of Drug Diversion Investigators (NADDI) is a non-profit 501(c)(3) organization that facilitates cooperation between law enforcement, healthcare professionals, state regulatory agencies and pharmaceutical manufacturers in the investigation and prevention of prescription drug abuse and diversion. NADDI also sponsors and conducts specialized educational seminars and conferences.


'/>"/>
SOURCE National Association of Drug Diversion Investigators (NADDI)
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Alliance Pharmaceutical Corp. Updates Oxygent(TM) Clinical Development Plan
2. Bristol-Myers Squibb and Gilead Sciences Expand Their Alliance to Include Commercialization of ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg) in Europe
3. Lung Cancer Alliance Commends NCCN on Screening Guidelines
4. Lung Cancer Alliance Hails Announcement of New Erbitux(R) Data
5. Alliance Pharmaceutical Corp. Announces Approval of Proposed Actions at Annual Shareholders Meeting
6. Vermillion Renews Strategic Alliance Agreement With Quest Diagnostics, Inc.
7. Ambrx and Merck Serono Expand Collaboration Through ARX424 Multiple Sclerosis Drug Development Alliance
8. ICON and MedAvante Sign Alliance Agreement
9. Pharmacyclics announces Global Strategic Alliance with Les Laboratoires Servier
10. Oxford BioTherapeutics and GlaxoSmithKline Form Strategic Alliance to Develop Novel Cancer Therapeutic Antibodies
11. SIRO Clinpharm and CambReg Ltd Strategic Alliance to Offer Regulatory Services in Europe
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/28/2017)... Sept. 28, 2017 Cohen Veterans Bioscience and ... use of wearable and home sensors for real-time monitoring ... Signal Foundation, a nonprofit organization focused on disruptive health ... an affordable analytical system to record and integrate behavioral, ... ...
(Date:9/27/2017)... NEW YORK , Sept. 27, 2017  DarioHealth Corp. (NASDAQ: ... data solutions, today announced that its MyDario product is expected to appear ... listings for when The Dr. Oz Show airs in your area: ... The nine-time Emmy award-winning, The ... ...
(Date:9/25/2017)... 25, 2017  EpiVax, Inc., a leader in ... immune-engineering today announced the launch of EpiVax Oncology ... personalized therapeutic cancer vaccines. EpiVax has provided $500,000 ... to enabling technologies to the new precision immunotherapy ... EpiVax Oncology as Chief Executive Officer. Gad brings ...
Breaking Medicine Technology:
(Date:10/12/2017)... ... October 12, 2017 , ... ... that we intend to develop to enable prevention of a major side effect ... hearing loss, especially in pediatric patients. For cisplatin, hearing loss is FDA listed ...
(Date:10/12/2017)... ... October 12, 2017 , ... HMP , a leader in ... 2017 Folio Magazine Eddie Digital Award for ‘Best B-to-B Healthcare Website.’ Winners were announced ... 2017. , The annual award competition recognizes editorial and design excellence across a range ...
(Date:10/12/2017)... Wesley Chapel, FL (PRWEB) , ... October 12, 2017 , ... ... Chapel is holding a treadmill relay – Miles by Moonlight to raise money for ... by donating $300 or more. , Teams will work together to keep their ...
(Date:10/12/2017)... ... October 12, 2017 , ... Health ... interactive health literacy software tool, and the Cancer Patient Education Network (CPEN), an ... education, today announce a new strategic alliance. , As CPEN’s strategic partner, ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... wound care advancements to physician colleagues, skilled nursing facility medical directors and other ... Treacherous Waters of Wound Care." , "At many of these conferences we get ...
Breaking Medicine News(10 mins):